Uzbekistan

Moving forward on TB treatment

MSF is now focusing on the particularly difficult issue of providing care for people with multidrug- resistant tuberculosis (TB).

A survey found that the Karakalpakstan area has the highest incidence of resistant TB in the Aral Sea region. MSF is now treating 100 patients there in an intensive DOTS–Plus (Directly Observed Treatment, Short-course) treatment program. This program builds on the regimen already in place and adds second-line drugs to overpower the resistant bacilli. Currently, MSF is exploring the potential of expanding the program to treat all patients with resistance in two pilot regions.

MSF has worked in Uzbekistan since 1997.

Field News | Contact Us | Donate | MSF Offices Worldwide | MSF on YouTube | MSF on Facebook

This site is maintained by the U.S. section of Doctors Without Borders/Médecins Sans Frontières (MSF), an international independent medical humanitarian organization that delivers emergency aid to people affected by armed conflict, epidemics, natural and man-made disasters, and exclusion from health care. © 2009 MSF All rights reserved.

MSF-USA Association | Copyright Statement | Privacy Policy